Grünenthal’s non-opioid pain drug gets breakthrough tag
pharmaphorum
MAY 23, 2023
Grünenthal’s non-opioid pain drug gets breakthrough tag Phil.Taylor Tue, 05/23/2023 - 08:20 Bookmark this
pharmaphorum
MAY 23, 2023
Grünenthal’s non-opioid pain drug gets breakthrough tag Phil.Taylor Tue, 05/23/2023 - 08:20 Bookmark this
STAT
APRIL 25, 2024
Senate Committee on Health, Education, Labor and Pensions is investigating the prices Novo Nordisk charges for its blockbuster medications, Ozempic and Wegovy, which are highly effective at treating diabetes and obesity but carry steep price tags, The New York Times writes. Bernie Sanders (I-Vt.),
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
MARCH 21, 2023
Lortab ( hydrocodone-acetaminophen ) is a type of opioid medication. Opioids should not be used as first-line therapy for short-term or chronic pain —with the exception being in end-of-life or palliative care, during active cancer treatment, and with sickle cell disease. Non-opioids should always be maximized before trialing opioids.
pharmaphorum
NOVEMBER 24, 2021
The DTx – also known as Pear-009 – is still in the proof-of-concept trial stage, but draws on the same cognitive behavioural therapy (CBT) deployed in Pear’s commercial-stage products reSET and reSET-O for people living with substance and opioid use disorders. Photo by thom masat on Unsplash.
The Checkup by Singlecare
MAY 8, 2023
Still, widespread and uncontrolled prescribing in the 1990s triggered the first wave of an epidemic in the misuse and overdoses of specific types of analgesic medications known as opioids. Between 1999-2020, more than 564,000 people died from an overdose involving any opioid medication, including both prescription and illicit opioids.
pharmaphorum
FEBRUARY 26, 2021
The company has also faced claims that it did not adequately communicate the risks of its opioid painkillers in its marketing, contributing to the US’ ‘opioid epidemic’, and that its talc products could contain small amounts of asbestos and lead to cancer. This is not the only controversy J&J has had to deal with in recent years.
Pharma Marketing Network
JUNE 8, 2020
I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.
Let's personalize your content